Amebiasis, also known as amoebiasis or amoebic dysentery, is an intestinal parasite infection caused by a microscopic parasite called Entamoeba histolytica or E. histolytica. Amebiasis is a global disease, but it is most common in impoverished tropical areas with poor sanitation and overcrowding, including Africa, Mexico, parts of South America, and India.
Read More
Amebiasis, a complex parasite infection, is a leading cause of diarrhea worldwide. As a result of limited research and understanding, renewed attention is required to help combat this infection of poverty. According to research by the National Institute of Health, the goal is to “develop innovative and inexpensive point-of-care diagnostic and surveillance tools, novel treatment options, and effective preventive strategies to help end amebiasis transmission.”
Read More
If you’ve diagnosed your patient with acute or chronic intestinal amebiasis, also known as amoebiasis or amoebic dysentery, or you want to provide an adjunctive therapy to patients with hepatic encephalopathy to manage hepatic coma, there are three ways to prescribe HUMATIN™ (paromomycin sulfate) capsules through the HUMATIN™ Total Care program. Regardless of which route you choose, the HUMATIN™ Total Care program focuses on safety, dosing education, and efficacy.
Read More
Amebiasis, also known as amoebiasis or amoebic dysentery, is a parasitic intestinal infection caused by a parasite called Entamoeba histolytica, or E. histolytica. This infection is caused by ingesting entamoeba histolytica cysts found in water, soil, or fertilizer contaminated with feces. The symptoms range from diarrhea, stomach pain, and stomach cramping to more severe effects of amebic dysentery, including bloody stool, fever, and severe stomach pain.
Read More